GLP-1 injectable solutions should be administered subcutaneously into the abdomen, thigh, or upper arm
In 2005, exenatide was approved as a kind of GLP-1 receptor agonists (GLP-1RAs) for the clinical treatment of type 2 diabetes mellitus (T2DM) as the first international incretin drug [6]
Although cost to patient will differ based on insurance, Table 4 shows the average wholesale price (AWP) of tirzepatide compared to other diabetes drug classes
Fortunately, the agent itself has an independent effect on curbing alcohol intake and cravings by affecting brain pathways related to reward and addiction
Nidhi Kansal, an obesity medicine doctor at Northwestern Medicine
For small molecules, this is well-established - it's the basis of nicotine patches, hormone replacement patches, and prescription pain patches